Emyria Ltd has released a press release.
Emyria Appoints Expert Neuropharmacologist for MDMA Program
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Emyria
- Emyria Executes Pure CBD Agreement with AltaSciences
- Emyria to Develop Novel Psychedelics Pipeline with UWA
- Emyria Advances EMD-004 Program Towards Registration
- Emyria Data Validated, Care Model Reduces Opioids
- Emyria Obtains TGA Approval for Medical Grade Monitoring App
Later from Emyria
- Emyria Engages Calvert Labs for Preclinical CBD studies
- MDMA-analogues Show Promise for Parkinsons Disease
- Emyria Expands Psychiatry Advisory for Psychedelics and MDMA
- Novel MDMA Analogue Screening Program Advanced
- Emyria selected to join Palantirs Foundry Builders Program
Follow Emyria into a list and get an email when it puts out news.
Follow Emyria